Literature DB >> 17505999

Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study.

Masaharu Yoshihara1, Toru Hiyama, Shigeto Yoshida, Masanori Ito, Shinji Tanaka, Yoshiyuki Watanabe, Ken Haruma.   

Abstract

OBJECTIVE: Pepsinogen testing is widely used in Japan as a method of screening for gastric cancer. To evaluate the efficacy of this method, a case-control study was conducted in a rural town in Hiroshima prefecture, Japan, where no previous pepsinogen testing had been performed.
MATERIAL AND METHODS: Three age-and gender-matched control subjects were randomly selected for each of 41 individuals who had died of gastric cancer. The three control subjects were selected from individuals who were living in the same area as the patient when gastric cancer was diagnosed.
RESULTS: The odds ratios for death from gastric cancer among control subjects screened within 1 and 2 years before the individuals were diagnosed versus those not screened were 0.238 (95% confidence interval (CI): 0.061-0.929), and 0.375 (95% CI: 0.155-0.905), respectively.
CONCLUSIONS: The study results suggest that gastric cancer screening using the pepsinogen method may reduce mortality from gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17505999     DOI: 10.1080/00365520601097351

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  16 in total

1.  Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer.

Authors:  Ying Zhou; Hai-Yan Li; Jing-Jing Zhang; Xiao-Yu Chen; Zhi-Zheng Ge; Xiao-Bo Li
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

Review 2.  Current issues and future perspectives of gastric cancer screening.

Authors:  Chisato Hamashima
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 3.  Screening and Preventive Strategies in Esophagogastric Cancer.

Authors:  Liam Zakko; Lori Lutzke; Kenneth K Wang
Journal:  Surg Oncol Clin N Am       Date:  2017-04       Impact factor: 3.495

4.  Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy.

Authors:  Takuji Gotoda; Hideki Ishikawa; Hirohide Ohnishi; Kentaro Sugano; Chika Kusano; Chizu Yokoi; Yutaka Matsuyama; Fuminori Moriyasu
Journal:  Gastric Cancer       Date:  2014-08-13       Impact factor: 7.370

5.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

6.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

7.  Serum pepsinogen levels indicate the requirement of upper gastrointestinal endoscopy among Group A subjects of ABC classification: a multicenter study.

Authors:  Daisuke Chinda; Tadashi Shimoyama; Tatsuya Mikami; Tetsu Arai; Daisuke Chiba; Yoshio Sasaki; Kazuo Komai; Yoshihiko Sawada; Yoshiharu Saito; Hironobu Chiba; Shinsaku Fukuda
Journal:  J Gastroenterol       Date:  2018-01-20       Impact factor: 7.527

8.  Helicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study.

Authors:  James William Keck; Karen M Miernyk; Lisa R Bulkow; Janet J Kelly; Brian J McMahon; Frank Sacco; Thomas W Hennessy; Michael G Bruce
Journal:  Can J Gastroenterol Hepatol       Date:  2014-06

Review 9.  Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review.

Authors:  Masanori Ito; Shunsuke Takata; Masana Tatsugami; Yoshihiro Wada; Shinobu Imagawa; Yoshiaki Matsumoto; Akemi Takamura; Shosuke Kitamura; Taiji Matsuo; Shinji Tanaka; Ken Haruma; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2009-04-01       Impact factor: 7.527

Review 10.  Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".

Authors:  Kazumasa Miki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.